CDC20 and glioma: We identified a unique CDC20+KIF20A+PTTG1+ high‐risk glioma cell subpopulation probably necessary for glioma progression of LGG/GBM transformation, which was further explored in multiple cohorts and validated in samples by immunohistochemistry and multiplex immunofluorescence assays.